138 related articles for article (PubMed ID: 28941610)
1. Scavenger Receptor LOX1 Genotype Predicts Coronary Artery Disease in Patients With Familial Hypercholesterolemia.
Paquette M; Dufour R; Baass A
Can J Cardiol; 2017 Oct; 33(10):1312-1318. PubMed ID: 28941610
[TBL] [Abstract][Full Text] [Related]
2. Elevated lipoprotein(a), hypertension and renal insufficiency as predictors of coronary artery disease in patients with genetically confirmed heterozygous familial hypercholesterolemia.
Chan DC; Pang J; Hooper AJ; Burnett JR; Bell DA; Bates TR; van Bockxmeer FM; Watts GF
Int J Cardiol; 2015 Dec; 201():633-8. PubMed ID: 26340131
[TBL] [Abstract][Full Text] [Related]
3. PHACTR1 genotype predicts coronary artery disease in patients with familial hypercholesterolemia.
Paquette M; Dufour R; Baass A
J Clin Lipidol; 2018; 12(4):966-971. PubMed ID: 29784573
[TBL] [Abstract][Full Text] [Related]
4. Contribution of receptor negative versus receptor defective mutations in the LDL-receptor gene to angiographically assessed coronary artery disease among young (25-49 years) versus middle-aged (50-64 years) men.
Gaudet D; Vohl MC; Couture P; Moorjani S; Tremblay G; Perron P; Gagné C; Després JP
Atherosclerosis; 1999 Mar; 143(1):153-61. PubMed ID: 10208490
[TBL] [Abstract][Full Text] [Related]
5. Significance of lipoprotein(a) levels in familial hypercholesterolemia and coronary artery disease.
Li S; Wu NQ; Zhu CG; Zhang Y; Guo YL; Gao Y; Li XL; Qing P; Cui CJ; Xu RX; Sun J; Liu G; Dong Q; Li JJ
Atherosclerosis; 2017 May; 260():67-74. PubMed ID: 28351002
[TBL] [Abstract][Full Text] [Related]
6. Relative contribution of low-density lipoprotein receptor and lipoprotein lipase gene mutations to angiographically assessed coronary artery disease among French Canadians.
Gaudet D; Vohl MC; Julien P; Tremblay G; Perron P; Gagné C; Bergeron J; Moorjani S; Després JP
Am J Cardiol; 1998 Aug; 82(3):299-305. PubMed ID: 9708657
[TBL] [Abstract][Full Text] [Related]
7. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
Jensen HK
Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
[TBL] [Abstract][Full Text] [Related]
8. PCSK9 R46L, lower LDL, and cardiovascular disease risk in familial hypercholesterolemia: a cross-sectional cohort study.
Saavedra YG; Dufour R; Davignon J; Baass A
Arterioscler Thromb Vasc Biol; 2014 Dec; 34(12):2700-5. PubMed ID: 25278291
[TBL] [Abstract][Full Text] [Related]
9. Genotype of the mutant LDL receptor allele is associated with LDL particle size heterogeneity in familial hypercholesterolemia.
Hogue JC; Lamarche B; Gaudet D; Tremblay AJ; Després JP; Gagné C; Couture P
Atherosclerosis; 2006 Jan; 184(1):163-70. PubMed ID: 15899484
[TBL] [Abstract][Full Text] [Related]
10. Greater preclinical atherosclerosis in treated monogenic familial hypercholesterolemia vs. polygenic hypercholesterolemia.
Sharifi M; Higginson E; Bos S; Gallivan A; Harvey D; Li KW; Abeysekera A; Haddon A; Ashby H; Shipman KE; Cooper JA; Futema M; Roeters van Lennep JE; Sijbrands EJG; Labib M; Nair D; Humphries SE
Atherosclerosis; 2017 Aug; 263():405-411. PubMed ID: 28549500
[TBL] [Abstract][Full Text] [Related]
11. Coronary artery disease in heterozygous familial hypercholesterolemia patients with the same LDL receptor gene mutation.
Ferrières J; Lambert J; Lussier-Cacan S; Davignon J
Circulation; 1995 Aug; 92(3):290-5. PubMed ID: 7634440
[TBL] [Abstract][Full Text] [Related]
12. Is LOX-1 K167N polymorphism protective for coronary artery disease?
Kurnaz O; Aydogan HY; Isbir CS; Tekeli A; Isbir T
In Vivo; 2009; 23(6):969-73. PubMed ID: 20023241
[TBL] [Abstract][Full Text] [Related]
13. Polygenic risk scores for low-density lipoprotein cholesterol and familial hypercholesterolemia.
Nomura A; Sato T; Tada H; Kannon T; Hosomichi K; Tsujiguchi H; Nakamura H; Takamura M; Tajima A; Kawashiri MA
J Hum Genet; 2021 Nov; 66(11):1079-1087. PubMed ID: 33967275
[TBL] [Abstract][Full Text] [Related]
14. Serum homocysteine, methylenetetrahydrofolate reductase gene polymorphism and cardiovascular disease in heterozygous familial hypercholesterolemia.
Pisciotta L; Cortese C; Gnasso A; Liberatoscioli L; Pastore A; Mannucci L; Irace C; Federici G; Bertolini S
Atherosclerosis; 2005 Apr; 179(2):333-8. PubMed ID: 15777550
[TBL] [Abstract][Full Text] [Related]
15. Remnant-like particles and coronary artery disease in familial hypercholesterolemia.
Tada H; Kawashiri MA; Nohara A; Sakata K; Inazu A; Mabuchi H; Yamagishi M; Hayashi K
Clin Chim Acta; 2018 Jul; 482():120-123. PubMed ID: 29626436
[TBL] [Abstract][Full Text] [Related]
16. Are IVS4 SNPs of OLR1 gene associated with coronary artery disease: Is there a linkage between IVS4 SNPs?
Kurnaz-Gomleksiz O; Kucukhuseyin O; Ozkok E; Bugra Z; Ozturk O; Yilmaz-Aydogan H
Adv Clin Exp Med; 2018 Mar; 27(3):321-326. PubMed ID: 29558038
[TBL] [Abstract][Full Text] [Related]
17. Polygenic risk score predicts prevalence of cardiovascular disease in patients with familial hypercholesterolemia.
Paquette M; Chong M; Thériault S; Dufour R; Paré G; Baass A
J Clin Lipidol; 2017; 11(3):725-732.e5. PubMed ID: 28456682
[TBL] [Abstract][Full Text] [Related]
18. Familial defective apolipoprotein B versus familial hypercholesterolemia: an assessment of risk.
Fouchier SW; Defesche JC; Kastelein JJ; Sijbrands EJ
Semin Vasc Med; 2004 Aug; 4(3):259-64. PubMed ID: 15630635
[TBL] [Abstract][Full Text] [Related]
19. A Chinese homozygote of familial hypercholesterolemia: identification of a novel C263R mutation in the LDL receptor gene.
Wang D; Wu B; Li Y; Heng W; Zhong H; Mu Y; Wang J
J Hum Genet; 2001; 46(3):152-4. PubMed ID: 11310584
[TBL] [Abstract][Full Text] [Related]
20. Application of expanded genetic analysis in the diagnosis of familial hypercholesterolemia in patients with very early-onset coronary artery disease.
Cao YX; Wu NQ; Sun D; Liu HH; Jin JL; Li S; Guo YL; Zhu CG; Gao Y; Dong QT; Liu G; Dong Q; Li JJ
J Transl Med; 2018 Dec; 16(1):345. PubMed ID: 30526649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
